Albumin modulates docosahexaenoic acid-induced cytotoxicity in human hepatocellular carcinoma cell lines

Toxicology Letters

Volumn 200, Issue 3, 2011, Pages 154-161

  Kanno, Syu ichi ^a   Kurauchi, Kaori ^a   Tomizawa, Ayako ^a   Yomogida, Shin ^a   Ishikawa, Masaaki ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Albumin; Antioxidant; Cytotoxicity; Docosahexaenoic acid; Reactive oxygen species

Indexed keywords

ALBUMIN; DEFEROXAMINE; DOCOSAHEXAENOIC ACID; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL LINE; CELL PROTECTION; CELL STRAIN HEP3B; CELL STRAIN HEPG2; CELL STRAIN HUH7; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALBUMINS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COLORING AGENTS; DNA, NEOPLASM; DOCOSAHEXAENOIC ACIDS; FREE RADICAL SCAVENGERS; HUMANS; INDICATORS AND REAGENTS; IRON CHELATING AGENTS; OXIDATION-REDUCTION; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, SMALL INTERFERING; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION;

EID: 78651076402     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.11.009     Document Type: Article

References (24)

1. Anderson B.M., Ma D.W. Are all n-3 polyunsaturated fatty acids created equal?. Lipids Health Dis. 2009, 8:33.
2. Arita K., Kobuchi H., Utsumi T., Takehara Y., Akiyama J., Horton A.A., Utsumi K. Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids. Biochem. Pharmacol. 2001, 62:821-828.
3. Bourdon E., Loreau N., Lagrost L., Blache D. Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin. Free Radic. Res. 2005, 39:15-20.
4. Caraceni P., Gasbarrini A., Van Thiel D.H., Borle A.B. Oxygen free radical formation by rat hepatocytes during postanoxic reoxygenation: scavenging effect of albumin. Am. J. Physiol. 1994, 266:G451-458.
5. Chapkin R.S., Hong M.Y., Fan Y.Y., Davidson L.A., Sanders L.M., Henderson C.E., Barhoumi R., Burghardt R.C., Turner N.D., Lupton J.R. Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids 2002, 37:193-199.
6. Chapkin R.S., Seo J., McMurray D.N., Lupton J.R. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem. Phys. Lipids 2008, 153:14-23.
7. Fukuzawa K., Saitoh Y., Akai K., Kogure K., Ueno S., Tokumura A., Otagiri M., Shibata A. Antioxidant effect of bovine serum albumin on membrane lipid peroxidation induced by iron chelate and superoxide. Biochim. Biophys. Acta 2005, 1668:145-155.
8. Gardner H.W. Oxygen radical chemistry of polyunsaturated fatty acids. Free Radic. Biol. Med. 1989, 7:65-86.
9. Kanno S., Higurashi A., Watanabe Y., Shouji A., Asou K., Ishikawa M. Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines. Toxicol. Lett. 2004, 152:149-158.
10. Kanno S., Shouji A., Asou K., Ishikawa M. Effects of naringin on hydrogen peroxide-induced cytotoxicity and apoptosis in P388 cells. J. Pharmacol. Sci. 2003, 92:166-170.
11. Kato T., Kolenic N., Pardini R.S. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr. Cancer 2007, 58:178-187.
12. Kiaer C., Thams P. Serum albumin protects from cytokine-induced pancreatic beta cell death by a phosphoinositide 3-kinase-dependent mechanism. Endocrine 2009, 35:325-332.
13. Lim K., Han C., Dai Y., Shen M., Wu T. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Mol. Cancer Ther. 2009, 8:3046-3055.
14. Maziere C., Conte M.A., Degonville J., Ali D., Maziere J.C. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem. Biophys. Res. Commun. 1999, 265:116-122.
15. Medina-Navarro R., Duran-Reyes G., Diaz-Flores M., Vilar-Rojas C. Protein antioxidant response to the stress and the relationship between molecular structure and antioxidant function. PLoS One 2010, 5:e8971.
16. Musante L., Bruschi M., Candiano G., Petretto A., Dimasi N., Del Boccio P., Urbani A., Rialdi G., Ghiggeri G.M. Characterization of oxidation end product of plasma albumin 'in vivo'. Biochem. Biophys. Res. Commun. 2006, 349:668-673.
17. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem. Sci. 2000, 25:502-508.
18. Roche M., Rondeau P., Singh N.R., Tarnus E., Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008, 582:1783-1787.
19. Rothschild M.A., Oratz M., Schreiber S.S. Serum albumin. Hepatology 1988, 8:385-401.
20. Rusca A., Di Stefano A.F., Doig M.V., Scarsi C., Perucca E. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers. Eur. J. Clin. Pharmacol. 2009, 65:503-510.
21. Strubelt O., Younes M., Li Y. Protection by albumin against ischaemia- and hypoxia-induced hepatic injury. Pharmacol. Toxicol. 1994, 75:280-284.
22. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
23. Watanabe A., Saito S., Tsuchida T., Higuchi K., Okita M. Low plasma levels of docosahexaenoic acid in patients with liver cirrhosis and its correction with a polyunsaturated fatty acid-enriched soft oil capsule. Nutrition 1999, 15:284-288.
24. Zand H., Rhimipour A., Bakhshayesh M., Shafiee M., Nour Mohammadi I., Salimi S. Involvement of PPAR-gamma and p53 in DHA-induced apoptosis in Reh cells. Mol. Cell. Biochem. 2007, 304:71-77.